1 unchanged sentence
Sale of Unregistered Securities.
−Removed: On May 1, 2025, the Company issued 10,830 shares of the Company's common stock, representing an aggregate value of approximately $226,000, to the members of MedTech Concepts LLC in lieu of the second anniversary cash payment otherwise required under the MedTech Purchase Agreement, dated May 1, 2023, by and among the Company, Kevin Unger, DINZE LLC, and the sole member of DINZE LLC.
−Removed: For more information, see the discussion under Note 3 - Business Combinations and Asset Acquisitions of the notes to the condensed consolidated financial statements included in Item 1.
−Removed: Financial Statements of Part I of this quarterly report on Form 10-Q, which discussion is incorporated herein by reference.
−Removed: The issuance of the common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended.
−Removed: On May 15, 2025, the Company issued 55,143 shares of the Company's common stock, representing an aggregate value of approximately $1,261,000, to Mighty Oak Medical, Inc.
−Removed: to satisfy the obligation that existed for past unmet minimum performance metrics.
−Removed: For more information, see the discussion under Note 12 - Commitments and Contingencies of the notes to the condensed consolidated financial statements included in Item 1.
−Removed: Financial Statements of Part I of this quarterly report on Form 10-Q, which discussion is incorporated herein by reference.
−Removed: The issuance of the common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended.
Use of Proceeds.
8 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.